{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:45:35Z","timestamp":1791805535438,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL159313"],"award-info":[{"award-number":["K23HL159313"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jtha.2022.09.003","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T19:21:20Z","timestamp":1673292080000},"page":"26-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia"],"prefix":"10.1016","volume":"21","author":[{"given":"Zain M.","family":"Virk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josanna","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingMing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.09.003_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00062752-199809000-00005","article-title":"Genetic abnormalities in hereditary hemorrhagic telangiectasia","volume":"5","author":"Marchuk","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.09.003_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0042-1743467","article-title":"Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians","volume":"48","author":"Al-Samkari","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.09.003_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2017.03.003","article-title":"Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: a cross-sectional survey","volume":"153","author":"Chaturvedi","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","article-title":"The natural history of epistaxis in hereditary hemorrhagic telangiectasia","volume":"101","author":"AAssar","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jtha.2022.09.003_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","article-title":"Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia","volume":"67","author":"Livesey","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jtha.2022.09.003_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH07-01-0064","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.09.003_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fgene.2015.00101","article-title":"Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia","volume":"6","author":"Shovlin","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.jtha.2022.09.003_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ajh.25925","article-title":"Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia","volume":"95","author":"Song","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2022.09.003_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3324\/haematol.2020.270496","article-title":"Recognition of thrombotic risk of thrombocytosis in iron deficiency","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.09.003_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.7326\/L21-0067","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"174","author":"Faughnan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2022.09.003_bib13","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3026(21)00164-2","article-title":"Giving hereditary haemorrhagic telangiectasia the attention it deserves","volume":"8","author":"Al-Samkari","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2022.09.003_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2020.10.019","article-title":"Bleeding events during anticoagulation in patients with hereditary hemorrhagic telangiectasia","volume":"197","author":"Tentoni","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.09.003_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2022.09.003_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-019-1172-8","article-title":"RIETE Investigators. Natural history of patients with\u00a0venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry","volume":"14","author":"Riera-Mestre","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2022.09.003_bib17","first-page":"1699","article-title":"Antithrombotic therapy in hereditary hemorrhagic telangiectasia: real-world data from the Gemelli Hospital HHT registry","volume":"9","author":"Gaetani","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2022.09.003_bib18","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00277-012-1553-8","article-title":"Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation","volume":"91","author":"Edwards","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2022.09.003_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.09.003_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2018.07.004","article-title":"Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia","volume":"169","author":"Chaturvedi","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.09.003_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jtha.2022.09.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jtha.2022.09.003_bib23","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.09.003_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/joim.12832","article-title":"Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"285","author":"Al-Samkari","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jtha.2022.09.003_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0194599818813521","article-title":"Systemic bevacizumab for hereditary hemorrhagic telangiectasia: considerations from observational studies","volume":"160","author":"Al-Samkari","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jtha.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/hae.14034","article-title":"An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"26","author":"Al-Samkari","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jth.15715","article-title":"A\u00a0precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies","volume":"20","author":"Al-Samkari","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.09.003_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2022.09.003_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants : a nationwide propensity score-weighted study","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2022.09.003_bib30","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/bjh.15606","article-title":"Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA","volume":"185","author":"Desjonqueres","year":"2019","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:32:56Z","timestamp":1761535976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1538783622071719"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.09.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}